| Literature DB >> 25290524 |
Nicole Reisinger1, Simone Schaumberger2, Veronika Nagl3, Sabine Hessenberger4, Gerd Schatzmayr5.
Abstract
The pathogenesis of laminitis is not completely identified and the role of endotoxins (lipopolysaccharides, LPS) in this process remains unclear. Phytogenic substances, like milk thistle (MT) and silymarin, are known for their anti-inflammatory and antioxidant properties and might therefore have the potential to counteract endotoxin induced effects on the hoof lamellar tissue. The aim of our study was to investigate the influence of endotoxins on lamellar tissue integrity and to test if MT and silymarin are capable of inhibiting LPS-induced effects in an in vitro/ex vivo model. In preliminary tests, LPS neutralization efficiency of these phytogenics was determined in an in vitro neutralization assay. Furthermore, tissue explants gained from hooves of slaughter horses were tested for lamellar separation after incubation with different concentrations of LPS. By combined incubation of explants with LPS and either Polymyxin B (PMB; positive control), MT or silymarin, the influence of these substances on LPS-induced effects was assessed. In the in vitro neutralization assay, MT and silymarin reduced LPS concentrations by 64% and 75%, respectively, in comparison PMB reduced 98% of the LPS concentration. In hoof explants, LPS led to a concentration dependent separation. Accordantly, separation force was significantly decreased by 10 µg/mL LPS. PMB, MT and silymarin could significantly improve tissue integrity of explants incubated with 10 µg/mL LPS. This study showed that LPS had a negative influence on the structure of hoof explants in vitro. MT and silymarin reduced endotoxin activity and inhibited LPS-induced effects on the lamellar tissue. Hence, MT and silymarin might be used to support the prevention of laminitis and should be further evaluated for this application.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25290524 PMCID: PMC4210879 DOI: 10.3390/toxins6102962
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Neutralization efficiency (%) of polymyxin (PMB), milk thistle (MT) and silymarin (SM) was tested with a LPS solution with a measured endotoxin activity of 43,533 EU/mL (±2433 EU/mL) at 37 °C for 2 h (n = 3 independent experiments). Error bars display standard deviation. a,b Superscripts indicate significant difference p < 0.05.
Figure 2Absorbance values at 450 nm measured with the WST-1 assay (n = 12 explants per treatment) to evaluate viability of explants after dissection, after 24 h and 48 h incubation with medium. Error bars display standard deviation. a,b Superscripts indicate significant difference p < 0.05.
Number of separated explants after LPS treatment (1.25–200 µg/mL) for 24 and 48 h. Contaminated explants (eight out of 293 explants in total) were excluded from results.
| Number of explants | ||
|---|---|---|
| Separated/total | Separated/total | |
| LPS (µg/mL) | 24 h | 48 h |
| 0 | 3/18 a | 0/32 a |
| 1.25 | n.d. | 0/8 a |
| 2.5 | 5/10 a | 0/12 a |
| 5 | 16/18 b | 4/12 a |
| 10 | 18/18 b | 6/12 a |
| 20 | 16/17 b | 11/11 b |
| 40 | 18/18 b | 12/12 b |
| 60 | n.d. | 8/8 b |
| 80 | n.d. | 9/9 b |
| 100 | 18/18 b | 12/12 b |
| 120 | n.d. | 9/9 b |
| 140 | n.d. | 9/9 b |
| 160 | n.d. | 9/9 b |
| 180 | n.d. | 9/9 b |
| 200 | 18/18 b | 12/12 b |
a,b Superscripts indicate significant difference p < 0.05.
Number of separated explants after treatment with medium, LPS (10 µg/mL) and LPS (10 µg/mL) combined with PMB (50–500 µg/mL) for 24 h. Contaminated explants (three out of 126 explants in total) were excluded from results.
| Treatment | Number of explants | |
|---|---|---|
| LPS (µg/mL) | PMB (µg/mL) | Separated/total |
| 0 | 0 | 3/30 a |
| 10 | 0 | 28/30 b |
| 10 | 50 | 2/8 a |
| 10 | 100 | 0/9 a |
| 10 | 200 | 6/20 a |
| 10 | 500 | 3/26 a |
a,b Superscripts indicate significant difference p < 0.05.
Number of separated explants after treatment with medium, LPS (10 µg/mL), MT (10–1000 µg/mL) combined with LPS (10 µg/mL) and silymarin (100 and 250 µg/mL) combined with LPS (10 µg/mL) for 24 h. Contaminated explants (three out of 66 explants in total) were excluded from results.
| Treatment | Number of explants | |
|---|---|---|
| LPS (µg/mL) | MT, silymarin (µg/mL) | Separated/total |
| 0 | 0 | 0/8 a |
| 10 | 0 | 9/9 b |
| 10 | MT 10 | 4/6 b |
| 10 | MT 100 | 3/9 b |
| 10 | MT 500 | 0/9 a |
| 10 | MT 1000 | 2/9 a |
| 10 | Silymarin 100 | 0/3 a |
| 10 | Silymarin 250 | 0/5 a |
a,b Superscripts indicate significant difference p < 0.05.
Figure 3Explants incubated with medium (control), 10 µg/mL LPS, polymyxin B (PMB) (200 µg/mL), milk thistle (MT) (1–1000 µg/mL) and silymarin (SM) (1–250 µg/mL) combined with 10 µg/mL LPS. Error bars display standard deviation. a,b Superscripts indicate significant difference p < 0.05.